Product News

Beyond Traditional Treatments: Exploring the Potential of PTCA Balloon Catheters

Over the years, medical professionals and hospitals are constantly seeking innovative solutions to overcome the challenges posed by tortuous anatomies. The treatment is more complicated and demanding because moderate to severe tortuosity affects about 40% of patients receiving percutaneous coronary intervention (PCI). APT Medical‘s Conqueror™ Lollipop NC PTCA Balloon Catheter with Spherical Tip will be the main topic of discussion as we explore the possibilities of PTCA balloon catheters. This innovative coronary catheter is intended to provide the best possible clinical outcomes for cardiovascular procedures by overcoming tortuosity.

One-of-a-kind Spherical Tip Design

During stent post-dilatation treatments, the Conqueror™ Lollipop NC PTCA Balloon Catheter has a high success rate when utilized as the first choice. Its spherical tip make it possible to glade through the stent in tortuous anatomy with ease, guaranteeing successful treatment. Medical providers can increase procedure success rates and improve patient outcomes by using this catheter.

Simplify the Advance of the Catheter

The Conqueror™ Lollipop NC PTCA Balloon Catheter has demonstrated a high success rate as a substitute for normal non-compliant (NC) balloons in situations when they are unable to produce the required outcomes in convoluted anatomies. Its specialized design and construction enable successful post-dilatation even in challenging scenarios. Providing medical professionals with this effective tool, empowers them to overcome obstacles and achieve optimal outcomes for patients.


With its high success rates as the first option, an alternative solution after regular NC balloon failure, and efficient design, this innovative device from APT Medical is set to revolutionize coronary catheters. As a leading manufacturer and supplier of Vascular Intervention medical devices, APT Medical is committed to advancing the field of interventional medicine.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button